Macquarie Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-122,622
Closed -$12.2M 2004
2019
Q3
$12.2M Sell
122,622
-15,972
-12% -$1.52M 0.02% 561
2019
Q2
$12.8M Sell
138,594
-63,501
-31% -$6.03M 0.02% 561
2019
Q1
$19.1M Sell
202,095
-238,791
-54% -$20.9M 0.03% 473
2018
Q4
$28.3M Sell
440,886
-23,661
-5% -$1.75M 0.05% 343
2018
Q3
$41.6M Buy
464,547
+114,074
+33% +$10.1M 0.07% 306
2018
Q2
$27.8M Buy
350,473
+10,815
+3% +$898K 0.05% 411
2018
Q1
$30.3M Sell
339,658
-1,719,786
-84% -$165M 0.06% 363
2017
Q4
$218M Sell
2,059,444
-2,802
-0.1% -$316K 0.39% 47
2017
Q3
$301M Sell
2,062,246
-132,872
-6% -$18.1M 0.54% 41
2017
Q2
$285M Sell
2,195,118
-285,384
-12% -$35M 0.52% 41
2017
Q1
$309M Sell
2,480,502
-127,809
-5% -$15.3M 0.56% 38
2016
Q4
$302M Sell
2,608,311
-221,803
-8% -$24.7M 0.58% 37
2016
Q3
$296M Sell
2,830,114
-411,892
-13% -$44.6M 0.57% 39
2016
Q2
$320M Sell
3,242,006
-309,237
-9% -$32M 0.63% 37
2016
Q1
$355M Sell
3,551,243
-130,718
-4% -$13.5M 0.72% 38
2015
Q4
$441M Sell
3,681,961
-89,621
-2% -$10.4M 0.91% 35
2015
Q3
$408M Buy
3,771,582
+8,638
+0.2% +$1.07M 0.87% 35
2015
Q2
$436M Sell
3,762,944
-238,175
-6% -$27.2M 0.86% 35
2015
Q1
$461M Sell
4,001,119
-64,908
-2% -$7.76M 0.91% 34
2014
Q4
$455M Sell
4,066,027
-624,968
-13% -$65.9M 0.94% 34
2014
Q3
$445M Sell
4,690,995
-103,637
-2% -$9.35M 0.95% 36
2014
Q2
$412M Sell
4,794,632
-8,144,548
-63% -$619M 0.92% 35
2014
Q1
$903M Buy
12,939,180
+632,928
+5% +$50.1M 1.56% 9
2013
Q4
$1.04B Sell
12,306,252
-46,208
-0.4% -$3.66M 1.86% 4
2013
Q3
$951M Buy
12,352,460
+444,866
+4% +$31.2M 1.86% 4
2013
Q2
$696M Buy
+11,907,594
New +$717M 1.52% 11

Other funds holding CELG

Macquarie Group's CELG Position: Q4 2019 in Review

Macquarie Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 122,622 shares — an estimated $12.2M sold.

Macquarie Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.04B in Q4 2013. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Macquarie Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Macquarie Group sold 122,622 Celgene Corp shares in Q4 2019, an estimated $12.2M.
  • Macquarie Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Macquarie Group's Celgene Corp position peaked at $1.04B in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Macquarie Group's 13F filing for Q4 2019, filed 14 Feb 2020.